(American College of Rheumatology) The American College of Rheumatology today applauded the decision from the Centers for Medicare & Medicaid Services (CMS) not to go forward with the agency's controversial Part B payment proposal, noting that the hard-fought outcome is good news for rheumatology patients who rely on Medicare Part B to access life-saving biologic therapies.
from EurekAlert! - Social and Behavioral Science http://ift.tt/2h9eMC4
No comments:
Post a Comment